The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant chemotherapy containing oxaliplatin without radiotherapy to improve survival of local advanced low and middle rectal cancer.
Ke-Feng Ding
No relevant relationships to disclose
Jun Li
No relevant relationships to disclose
Yong-Mao Song
No relevant relationships to disclose
Jian-Wei Wang
No relevant relationships to disclose
Ying Yuan
No relevant relationships to disclose
Suzhan Zhang
No relevant relationships to disclose